FAST NEWS: Genetron’s Losses Grow as Covid Restrictions Hurt Business
The latest: Cancer-screening device maker Genetron Holdings Ltd. (GTH.US) said on Thursday its revenue grew 9.6% year-on-year in the fourth quarter to 146.9 million yuan ($23 million). Its loss for…
RELATED ARTICLES
-
Cash-strapped Mirxes looks for lifeline in blood-based cancer detection
-
Everest Medicines drives growth with AI-powered mRNA pipeline
1952.HK
- Atour relies on network expansion to counter economic slowdown
-
After 14 years of losses, Zhihu finds an answer to its profitability question
2390.HK ZH.US
-
Overseas losses put wrinkle in H World’s welcome mat
1179.HK HTHT.US
-
Yalla revenue growth returns to double-digits ahead of new gaming push
YALA.US
-
Its knuckles rapped, recovering Gaotu springs back to the black
GOTU.US
